Anti-PD-1 (PD-1 inhibitor)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-PD-1 (PD-1 inhibitor), covering 2026-03-03 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]